Proteostasis Therapeutics   Report issue

For profit Phase 1 Phase 2
Founded: Cambridge MA United States (2007)
Status: Acquired by Yumanity (2020)

Organization Overview

First Clinical Trial
2016
NCT02846142
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Proteostasis Therapeutics, Inc.